Rigontec: Corporate News Blog - Merck to Acquire German immuno-oncology Company Rigontec

(4-traders.com) Research Desk Line-up: Impax Laboratories Post Earnings Coverage LONDON, UK / ACCESSWIRE / September 8, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Merck & Co., Inc. (NYSE: MRK) ("Merck"), following which we have published a free report that can be viewed by signing up at...http://www.4-traders.com/news/Corporate-News-Blog-Merck-to-Acquire-German-immuno-oncology-Company-Rigontec--25084128/